DK1443943T3 - Fremgangsmåder til reaktion af alkaloider og anvendelse af reaktionsprodukterne ved tilberedning af medikamenter - Google Patents

Fremgangsmåder til reaktion af alkaloider og anvendelse af reaktionsprodukterne ved tilberedning af medikamenter

Info

Publication number: DK1443943T3
Authority: DK; Denmark
Prior art keywords: reaction; alkaloids; medicaments; preparation; methods
Prior art date: 2001-11-15

Application number

DK02783017.3T

Other languages

English (en)

Inventor

Wassyl Nowicky

Original Assignee

Nowicky Wassili

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-15

Filing date

2002-10-28

Publication date

2011-02-14

2002-10-28 Application filed by Nowicky Wassili filed Critical Nowicky Wassili

2011-02-14 Application granted granted Critical

2011-02-14 Publication of DK1443943T3 publication Critical patent/DK1443943T3/da

Links

229930013930 alkaloid Natural products 0.000 title 1
239000007795 chemical reaction product Substances 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000000034 method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
- C07G5/00—Alkaloids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/564—Three-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/6533—Six-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
- C07F9/65846—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a six-membered ring which may be condensed with another ring system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Pulmonology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK02783017.3T 2001-11-15 2002-10-28 Fremgangsmåder til reaktion af alkaloider og anvendelse af reaktionsprodukterne ved tilberedning af medikamenter DK1443943T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH02094/01A CH695417A5 (de)	2001-11-15	2001-11-15	Verfahren zur Umsetzung von Alkaloiden.
PCT/EP2002/012003 WO2003041721A1 (en)	2001-11-15	2002-10-28	Process for reacting alkaloids and use of the reaction products in the preparation of medicaments

Publications (1)

Publication Number	Publication Date
DK1443943T3 true DK1443943T3 (da)	2011-02-14

Family

ID=4567486

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02783017.3T DK1443943T3 (da)	2001-11-15	2002-10-28	Fremgangsmåder til reaktion af alkaloider og anvendelse af reaktionsprodukterne ved tilberedning af medikamenter

Country Status (38)

Country	Link
US (1)	US20050043340A1 (da)
EP (1)	EP1443943B1 (da)
JP (1)	JP2005509006A (da)
KR (1)	KR100849488B1 (da)
CN (1)	CN100436462C (da)
AR (1)	AR037527A1 (da)
AT (1)	ATE485826T1 (da)
AU (1)	AU2002346888B2 (da)
BR (1)	BR0214173A (da)
CA (1)	CA2465723C (da)
CH (1)	CH695417A5 (da)
CO (1)	CO5580784A2 (da)
CR (1)	CR7340A (da)
CU (1)	CU23451B7 (da)
CY (1)	CY1111139T1 (da)
DE (1)	DE60238134D1 (da)
DK (1)	DK1443943T3 (da)
EA (1)	EA007097B1 (da)
EC (1)	ECSP045107A (da)
ES (1)	ES2353207T3 (da)
GE (1)	GEP20053701B (da)
HR (1)	HRP20040430A2 (da)
HU (1)	HU229688B1 (da)
IL (2)	IL161766A0 (da)
IS (1)	IS2812B (da)
MA (1)	MA26232A1 (da)
MX (1)	MXPA04004643A (da)
NO (1)	NO334701B1 (da)
NZ (1)	NZ532941A (da)
PL (1)	PL212111B1 (da)
PT (1)	PT1443943E (da)
RS (1)	RS51219B (da)
SA (1)	SA02230496B1 (da)
TN (1)	TNSN04084A1 (da)
TW (1)	TWI262080B (da)
UA (1)	UA76535C2 (da)
WO (1)	WO2003041721A1 (da)
ZA (1)	ZA200403371B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1459753A1 (en)	2003-03-18	2004-09-22	Nowicky, Wassyl, Dipl.-Ing. DDr.	Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments
WO2006053649A1 (en) *	2004-11-19	2006-05-26	Nowicky Wassili	Method for the detection of cancer
WO2006053680A1 (en) *	2004-11-19	2006-05-26	Nowicky Wassili	Ex vivo cancer diagnostic method
WO2007073919A2 (en)	2005-12-28	2007-07-05	Nowicky Wassili	Method and kit for the detection of cancer
ITMI20080284A1 (it) *	2008-02-22	2009-08-23	Indena Spa	Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono
CA2941315C (en) *	2016-08-12	2018-03-06	Api Labs Inc.	High thebaine poppy and methods of producing the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3865830A (en) *	1969-06-16	1975-02-11	Nikolai Mikhailovich Turkevich	Thiophosphamide derivatives of isoquinoline alkaloids, method of producing and application thereof
SU368254A1 (ru) *	1969-06-16	1973-01-26	А. И. Потопальский , В. М. Новицкий Львовский государственный медицинский институт	Способ получения соединений тиофосфамида с алкалоидами чистотела большого
AT354644B (de) *	1975-12-19	1980-01-25	Nowicky Wassili	Verfahren zur herstellung von neuen salzen von alkaloidderivaten von thiophosphorsaeure
AT377988B (de) *	1976-06-28	1985-05-28	Nowicky Wassili	Verfahren zur herstellung von neuen phosphorderivaten von alkaloiden
DE3128018A1 (de) *	1981-07-13	1983-04-07	Wassyl 1060 Wien Nowicky	"verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4970212A (en) *	1982-05-18	1990-11-13	Nowicky Wassili	Method of treating human illnesses which compromise the ability to mount an effective immunological response
AT407608B (de) *	1994-03-18	2001-05-25	Nowicky Wassili	Mittel zur behandlung von osteoporose
AT407833B (de) *	1995-06-01	2001-06-25	Nowicky Wassyl Dr	Mittel zur behandlung von strahlenschäden
AT408719B (de) *	2000-03-22	2002-02-25	Nowicky Wassili	Mittel zur behandlung von hepatitis c

2001
- 2001-11-15 CH CH02094/01A patent/CH695417A5/de not_active IP Right Cessation
2002
- 2002-10-25 TW TW091125317A patent/TWI262080B/zh not_active IP Right Cessation
- 2002-10-28 WO PCT/EP2002/012003 patent/WO2003041721A1/en not_active Ceased
- 2002-10-28 RS YUP-408/04A patent/RS51219B/sr unknown
- 2002-10-28 KR KR1020047007480A patent/KR100849488B1/ko not_active Expired - Fee Related
- 2002-10-28 AU AU2002346888A patent/AU2002346888B2/en not_active Ceased
- 2002-10-28 ES ES02783017T patent/ES2353207T3/es not_active Expired - Lifetime
- 2002-10-28 IL IL16176602A patent/IL161766A0/xx unknown
- 2002-10-28 BR BR0214173-6A patent/BR0214173A/pt not_active IP Right Cessation
- 2002-10-28 MX MXPA04004643A patent/MXPA04004643A/es active IP Right Grant
- 2002-10-28 PL PL368879A patent/PL212111B1/pl unknown
- 2002-10-28 CA CA002465723A patent/CA2465723C/en not_active Expired - Fee Related
- 2002-10-28 EA EA200400679A patent/EA007097B1/ru not_active IP Right Cessation
- 2002-10-28 UA UA20040604558A patent/UA76535C2/uk unknown
- 2002-10-28 DK DK02783017.3T patent/DK1443943T3/da active
- 2002-10-28 HR HR20040430A patent/HRP20040430A2/hr not_active IP Right Cessation
- 2002-10-28 HU HU0402365A patent/HU229688B1/hu unknown
- 2002-10-28 NZ NZ532941A patent/NZ532941A/en not_active IP Right Cessation
- 2002-10-28 AT AT02783017T patent/ATE485826T1/de active
- 2002-10-28 GE GE8206A patent/GEP20053701B/en unknown
- 2002-10-28 JP JP2003543608A patent/JP2005509006A/ja active Pending
- 2002-10-28 DE DE60238134T patent/DE60238134D1/de not_active Expired - Lifetime
- 2002-10-28 US US10/495,729 patent/US20050043340A1/en not_active Abandoned
- 2002-10-28 EP EP02783017A patent/EP1443943B1/en not_active Expired - Lifetime
- 2002-10-28 PT PT02783017T patent/PT1443943E/pt unknown
- 2002-11-15 CN CNB021513384A patent/CN100436462C/zh not_active Expired - Fee Related
- 2002-11-15 AR ARP020104397A patent/AR037527A1/es unknown
- 2002-12-30 SA SA02230496A patent/SA02230496B1/ar unknown
2004
- 2004-04-30 IS IS7245A patent/IS2812B/is unknown
- 2004-05-04 ZA ZA200403371A patent/ZA200403371B/en unknown
- 2004-05-04 IL IL161766A patent/IL161766A/en not_active IP Right Cessation
- 2004-05-05 NO NO20041845A patent/NO334701B1/no not_active IP Right Cessation
- 2004-05-11 CR CR7340A patent/CR7340A/es unknown
- 2004-05-13 TN TNP2004000084A patent/TNSN04084A1/en unknown
- 2004-05-14 EC EC2004005107A patent/ECSP045107A/es unknown
- 2004-05-14 MA MA27679A patent/MA26232A1/fr unknown
- 2004-05-17 CU CU20040105A patent/CU23451B7/es not_active IP Right Cessation
- 2004-06-01 CO CO04051024A patent/CO5580784A2/es not_active Application Discontinuation
2011
- 2011-01-24 CY CY20111100077T patent/CY1111139T1/el unknown

Also Published As

Publication number	Publication date
ZA200403371B (en)	2005-05-04
MA26232A1 (fr)	2004-07-01
HUP0402365A2 (hu)	2005-02-28
HU229688B1 (en)	2014-04-28
CO5580784A2 (es)	2005-11-30
EA007097B1 (ru)	2006-06-30
KR100849488B1 (ko)	2008-07-31
ES2353207T3 (es)	2011-02-28
NO20041845D0 (no)	2004-05-05
EA200400679A1 (ru)	2004-10-28
EP1443943B1 (en)	2010-10-27
CN100436462C (zh)	2008-11-26
RS51219B (sr)	2010-12-31
TNSN04084A1 (en)	2006-06-01
ECSP045107A (es)	2004-06-28
IL161766A0 (en)	2005-11-20
AR037527A1 (es)	2004-11-17
TWI262080B (en)	2006-09-21
MXPA04004643A (es)	2005-03-14
SA02230496B1 (ar)	2008-09-10
CY1111139T1 (el)	2015-06-11
NO20041845L (no)	2004-06-25
CR7340A (es)	2004-12-06
JP2005509006A (ja)	2005-04-07
HRP20040430A2 (en)	2004-08-31
BR0214173A (pt)	2004-09-28
GEP20053701B (en)	2005-12-12
KR20050040859A (ko)	2005-05-03
DE60238134D1 (de)	2010-12-09
AU2002346888B2 (en)	2007-03-22
US20050043340A1 (en)	2005-02-24
WO2003041721A1 (en)	2003-05-22
ATE485826T1 (de)	2010-11-15
CU23451B7 (es)	2009-10-16
PT1443943E (pt)	2010-12-03
IL161766A (en)	2009-11-18
IS2812B (is)	2012-11-15
IS7245A (is)	2004-04-30
RS40804A (sr)	2006-12-15
NZ532941A (en)	2006-08-31
PL212111B1 (pl)	2012-08-31
CN1422859A (zh)	2003-06-11
CH695417A5 (de)	2006-05-15
CA2465723C (en)	2010-01-05
HK1054041A1 (zh)	2003-11-14
AU2002346888C1 (en)	2003-05-26
PL368879A1 (en)	2005-04-04
HRP20040430B1 (da)	2012-11-30
UA76535C2 (en)	2006-08-15
NO334701B1 (no)	2014-05-12
CA2465723A1 (en)	2003-05-22
EP1443943A1 (en)	2004-08-11

Publication	Publication Date	Title
NO20022176D0 (no)	2002-05-07	Absorberende gjenstand og fremgangsmåte for fremstilling av denne
NO20030870D0 (no)	2003-02-25	Bicykliske heterocykler, medikamenter inneholdende disse, deres anvendelseog fremgansgmåte for fremstilling derav
NO20051493D0 (no)	2005-03-21	Imidazolpyridiner og fremgangsmater for fremstilling og anvendelse av de samme
EE200300369A (et)	2003-10-15	Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
DK1345910T3 (da)	2009-07-20	Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
DK1180518T3 (da)	2007-05-21	5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO20016185D0 (no)	2001-12-18	Bicykliske heterocykler, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstillingderav
DK1423376T3 (da)	2010-06-28	Bicyklisk forbindelse, fremstilling og anvendelse deraf
DE60237064D1 (de)	2010-09-02	Lithium-enthaltendes Siliciumoxidpulver und Verfahren zu dessen Herstellung
DK1183029T3 (da)	2005-11-14	Farmaceutisk præparat indeholdende diamorfin og vitamin E og dets anvendelse til behandling af opiatmisbrug
DK1341414T3 (da)	2013-03-25	Marint actinomycet-taxon til opdagelse af medikamenter og fermenteringsprodukter
NO20015542D0 (no)	2001-11-13	Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20015659D0 (no)	2001-11-20	Purinderivater, fremstillingsmetode og farmasöytiske preparater inneholdende disse
AU2003255612A8 (en)	2003-12-19	Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
NO20016404L (no)	2002-03-01	Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
NO20034413D0 (no)	2003-10-02	Beta-karbolinderivater og deres farmasöytiske anvendelse mot depresjon og angst
NO20003555L (no)	2002-01-11	Fremgangsmåte ved fremstilling av konstruksjonselementer og de resulterende elementer
DK1443943T3 (da)	2011-02-14	Fremgangsmåder til reaktion af alkaloider og anvendelse af reaktionsprodukterne ved tilberedning af medikamenter
HUP0303055A3 (en)	2004-11-29	Polymorphs of zaleplon and methods for the preparation thereof and pharmaceutical compositions containing them
NO20043295L (no)	2004-08-06	Faste salt-benzazepinforbindelser og deres anvendelse ved fremstilling av farmasoytiske forbindelser
IS5627A (is)	2000-09-12	Svefnlyfs ß-karbólín afleiður, aðferð til framleiðslu á þeim og notkun þeirra sem læknislyfja
NO20033120D0 (no)	2003-07-08	2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
DK1241169T3 (da)	2003-11-24	Isoindoloindolonforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1466604T3 (da)	2008-03-03	Isoquinolinderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf ved behandling af metatoninerge problemsystemer
DK1341758T3 (da)	2006-10-30	Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme